Lucintel Newsletter

Business News by Lucintel

Bookmark and Share

Monday, November 29, 2021

Lucintel Forecasts Metagenomic Market to Grow at a CAGR of 16%-18%

According to the recent study the metagenomic market is projected to grow at a CAGR of 16%-18% from 2020 to 2026. Growth in this market is primarily driven by surge in the metagenomic experiment collaboration, adoption of metagenomic applications, and growing advanced sequencing platforms.

Browse XX figures / charts and XX tables in this 150-page report to understand trends, opportunities and forecast in metagenomic market by product (instrument & software and consumables), technology (sequencing and bioinformatics), application (infectious disease diagnosis, environmental remediation, gut microbe characterization, biotechnology, biofuel, and agriculture) and region (North America, Europe, Asia Pacific, and Rest of the World).

Download sample report and view detailed Table of Content by clicking on below link https://www.lucintel.com/metagenomic-market.aspx

“Consumables market is expected to remain the largest segment during the forecast period.”      

Based on product, the metagenomic market is segmented into instrument & software and consumables. Lucintel forecasts that the consumables market is expected to remain the largest segment during the forecast period due to their high adoption in the pre-sequencing, which is one of the most important steps in the overall metagenomic sequencing protocol. Therefore, this factor continues to contribute to the dominant position of this segment in the market.

“Within the metagenomic market, the gut microbe characterization segment is expected to remain the largest application.”    

Based on application, the gut microbe characterization segment is expected to witness the largest segment over the forecast period due to human intestinal microbiota is a homeostatic ecosystem, which has a significant impact on human health, and the disruption of this equilibrium leads to increased susceptibility to infections by various pathogens.

“North America will dominate the metagenomic market in near future.”

North America is expected to be the largest region over the forecast period due to increasing implementation of DNA sequencing across metagenomic applications in this region. In addition, rapid adoption of novel sequencing technologies in this region has contributed to its dominance.

Download Brochure of this report by clicking on https://www.lucintel.com/metagenomic-market.aspx

Major players of metagenomic market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Agilent Technologies, Enterome, F. Hoffmann-La Roche, Illumina, Oxford Nanopore Technologies, Pacific Biosciences of California, PerkinElmer, Qiagen, Swift Biosciences, and Thermo Fisher Scientific are among the major metagenomic providers.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/metagenomic-market.aspx or helpdesk@lucintel.com.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times. For further information, visit www.lucintel.com.

Contact:
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email:
brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751


Related reports

Surgical Instrument Tracking System Market:

For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx

 

Metabolomics Market:

For more details click here https://www.lucintel.com/metabolomics-market.aspx

 

Industrial Microbiology Market:

For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx

 

Surgical Microscope Market:

For more details click here https://www.lucintel.com/surgical-microscope-market.aspx

 

Tumor Ablation Market:

For more details click here https://www.lucintel.com/tumor-ablation-market.aspx

 

Vitamin D Market:

For more details click here https://www.lucintel.com/vitamin-d-market.aspx

 

Urology Device Market:

For more details click here https://www.lucintel.com/urology-device-market.aspx

 

Halal Ingredient Market:

For more details click here https://www.lucintel.com/halal-ingredient-market.aspx

 

Gene Expression Market:

For more details click here https://www.lucintel.com/gene-expression-market.aspx

 

GMO Testing Market:

For more details click here https://www.lucintel.com/gmo-testing-market.aspx


Forensic DNA market is expected to grow at a CAGR of 6%-8% by 2026- An exclusive market research report by Lucintel

Lucintel's latest market report analyzed that forensic DNA provides attractive opportunities in pharmacogenetics, biodefense & biosurveillance, and judicial/law enforcement. The forensic DNA market is expected to grow at a CAGR of 6%-8%. In this market, capillary electrophoresis are the largest segment by type, whereas judicial/law enforcement are largest by application.        

Download Brochure of this report by clicking on https://www.lucintel.com/forensic-dna-market.aspx

Based on type, the forensic DNA market is segmented into polymerase chain reaction (PCR), capillary electrophoresis, next-generation sequencing (NGS), rapid DNA analysis, automated liquid handling technology, microarrays, and others. The capillary electrophoresis segment accounted for the largest share of the market in 2020 due to factors, such as increased resolution, reduced risk of cross-contamination, online detection, higher speed, minimal consumption of sample, and easy-to-use techniques. 

Browse in-depth TOC on “Forensic DNA Market”

XX – Tables

XX – Figures

150– Pages

The forensic DNA market is marked by the presence of several big and small players. Some of the prominent players offering forensic DNA include CSL Behring, ADMA Biologics, Grifols, Shire, Pfizer, GeNeuro, Gilead Sciences, Galapagos, Astellas Pharma, AbbVie, and Mitsubishi Tanabe Pharma Corporation.  

Request Sample Report:

https://www.lucintel.com/forensic-dna-market.aspx

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: 
brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751


Related reports

Surgical Instrument Tracking System Market:

For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx

 

Metabolomics Market:

For more details click here https://www.lucintel.com/metabolomics-market.aspx

 

Industrial Microbiology Market:

For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx

 

Surgical Microscope Market:

For more details click here https://www.lucintel.com/surgical-microscope-market.aspx

 

Tumor Ablation Market:

For more details click here https://www.lucintel.com/tumor-ablation-market.aspx

 

Vitamin D Market:

For more details click here https://www.lucintel.com/vitamin-d-market.aspx

 

Urology Device Market:

For more details click here https://www.lucintel.com/urology-device-market.aspx

 

Halal Ingredient Market:

For more details click here https://www.lucintel.com/halal-ingredient-market.aspx

 

Gene Expression Market:

For more details click here https://www.lucintel.com/gene-expression-market.aspx

 

GMO Testing Market:

For more details click here https://www.lucintel.com/gmo-testing-market.aspx

Diagnostic specialty antibody market is expected to grow at a CAGR of 4%-6% by 2026- An exclusive market research report by Lucintel

Lucintel's latest market report analyzed that diagnostic specialty antibody provides attractive opportunities in hospitals and diagnostic laboratories. The diagnostic specialty antibodymarket is expected to grow at a CAGR of 4%-6%. In this market, monoclonal antibodiesare the largest segment by antibody type, whereas gut microbe characterizationare largest by application.

Download Brochure of this report by clicking on https://www.lucintel.com/diagnostic-specialty-antibody-market.aspx

Based on antibody type, the diagnostic specialty antibody market is segmented intomonoclonal antibodies, polyclonal antibodies, and recombinant polyclonal antibodies.The monoclonal antibodiessegment accounted for the largest share of the market in 2020as monoclonal antibodies play a vital role in the diagnosis of many infectious and chronic diseases, such as cancer. Also, an increase in the importance of monoclonal antibodies in scientific research for generation is projected to boost this segment over the forecast period.

Browse in-depth TOC on “Diagnostic Specialty AntibodyMarket”

XX – Tables

XX – Figures

150– Pages

The diagnostic specialty antibodymarket is marked by the presence of several big and small players. Some of the prominent players offering diagnostic specialty antibodyinclude Abcam, Sanofi, Abbott laboratories, Hoffmann-La Roche, Danaher, Bio-Rad Laboratories, BoehringerIngelheim International, Agilent Technologies, and AytuBioScience.  

Request Sample Report:

https://www.lucintel.com/diagnostic-specialty-antibody-market.aspx

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: 
brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751

Related reports

Surgical Instrument Tracking System Market:

For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx

 

Metabolomics Market:

For more details click here https://www.lucintel.com/metabolomics-market.aspx

 

Industrial Microbiology Market:

For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx

 

Surgical Microscope Market:

For more details click here https://www.lucintel.com/surgical-microscope-market.aspx

 

Tumor Ablation Market:

For more details click here https://www.lucintel.com/tumor-ablation-market.aspx

 

Vitamin D Market:

For more details click here https://www.lucintel.com/vitamin-d-market.aspx

 

Urology Device Market:

For more details click here https://www.lucintel.com/urology-device-market.aspx

 

Halal Ingredient Market:

For more details click here https://www.lucintel.com/halal-ingredient-market.aspx

 

Gene Expression Market:

For more details click here https://www.lucintel.com/gene-expression-market.aspx

 

GMO Testing Market:

For more details click here https://www.lucintel.com/gmo-testing-market.aspx


 

Lucintel Forecasts Biotherapeutics Cell Line Development Market to Grow at a CAGR of 6%-8%

According to the recent study the biotherapeutics cell line development market is projected to grow at a CAGR of 6%-8% from 2020 to 2026. Growth in this market is primarily driven by increase in geriatric population and prevalence of diseases, government initiatives to boost biotechnology & pharmaceutical sectors, and development of advanced technologies to cater to the rising demand for monoclonal antibodies.

Browse XX figures / charts and XXtables in this 150-page report to understand trends, opportunities and forecast in biotherapeuticscell line developmentmarketby process (transfection & selection and single cell cloning and consumable), CLD option (in-house, outsourced, do-it-yourself, and hybrid), and region (North America, Europe, Asia Pacific, and Rest of the World).

Download sample report and view detailed Table of Content by clicking on below link https://www.lucintel.com/biotherapeutics-cell-line-development-market.aspx

“Transfection & selection and single cell cloning market is expected to remain the largest segment during the forecast period.”

Based on process, the biotherapeutics cell line development market is segmented intotransfection & selection and single cell cloning and consumable. Lucintel forecasts that the transfection & selection and single cell cloning market is expected to remain the largest segment during the forecast perioddue to rise in demand for biotherapeutics, increase in adoption of instruments, such as FACS (Fluorescence-Activated Cell Sorting) &ClonePix, and higher throughput nature of this method.

“Within the biotherapeutics cell line development market, the outsource segment is expected to remain the largest CLD Option.”

Based on CLD Option, the outsource segment is expected to witness the largest segment over the forecast period due to increase in demand for outsourced products, cost saving, and rapid delivery of products are some of the major factors that drive the outsource segment.

“North America will dominate the biotherapeutics cell line development market in near future.”

North America is expected to be the largest region over the forecast period due to high funding in new biological drugs, rise in geriatric population, increase in prevalence of various diseases in the developed countries of the region, and growth in government funding for research and development activities.

Download Brochure of this report by clicking on https://www.lucintel.com/biotherapeutics-cell-line-development-market.aspx

Major players of biotherapeutics cell line development market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Merck KGaA, Becton, Dickinson and Company (BD), Danaher, BoehringerIngelheim Group, Thermo Fisher Scientific, Lonza Group, Probiogen, Solentim, Selexis, and Sysmexare among the major biotherapeutics cell line development providers.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/biotherapeutics-cell-line-development-market.aspxor or helpdesk@lucintel.com.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market &unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times. For further information, visit www.lucintel.com.

Contact:
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email:
brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751

Related reports

Surgical Instrument Tracking System Market:

For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx

 

Metabolomics Market:

For more details click here https://www.lucintel.com/metabolomics-market.aspx

 

Industrial Microbiology Market:

For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx

 

Surgical Microscope Market:

For more details click here https://www.lucintel.com/surgical-microscope-market.aspx

 

Tumor Ablation Market:

For more details click here https://www.lucintel.com/tumor-ablation-market.aspx

 

Vitamin D Market:

For more details click here https://www.lucintel.com/vitamin-d-market.aspx

 

Urology Device Market:

For more details click here https://www.lucintel.com/urology-device-market.aspx

 

Halal Ingredient Market:

For more details click here https://www.lucintel.com/halal-ingredient-market.aspx

 

Gene Expression Market:

For more details click here https://www.lucintel.com/gene-expression-market.aspx

 

GMO Testing Market:

For more details click here https://www.lucintel.com/gmo-testing-market.aspx

Friday, November 26, 2021

Vitamin D Market is expected to grow at a CAGR of 10%-12% from 2020 to 2025- An exclusive market research report by Lucintel

Lucintel's latest market report analyzed that vitamin D provides attractive opportunities in functional food and beverage, pharmaceutical, animal feed and pet food, and personal care applications. The Vitamin D market is expected to grow at a CAGR of 10%-12%. In this market, vitamin D2 is the largest segment by analog, whereas pharmaceuticals is largest by application.

Download Brochure of this report by clicking on https://www.lucintel.com/vitamin-d-market.aspx

Based on analog, the vitamin D market is segmented into vitamin D2 and vitamin D3. The vitamin D2 segment accounted for the largest share of the market in 2020 and is expected to register the highest CAGR during the forecast period, due to the wide applications of vitamin D2.

Browse in-depth TOC on “Vitamin D Market”

XX– Tables

XX – Figures

150 – Pages

The Vitamin D Market is marked by the presence of several big and small players. Some of the prominent players offering vitamin D include Archer Daniels Midland, Nestlé, Taizhou Haisheng Pharmaceutical, Pfizer, Groupe Danone, Abbott Laboratories, BASF, Koninklijke DSM, and Fermenta Biotech.

Request Sample Report:

https://www.lucintel.com/vitamin-d-market.aspx

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: 
brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751

Related reports

Minimally Invasive Surgical Instrument Market:

For more details click here https://www.lucintel.com/minimally-invasive-surgical-instrument-market.aspx

 

Endoscopy Equipment Market:

For more details click here https://www.lucintel.com/endoscopy-equipment-market.aspx

 

MicroRNA Market:

For more details click here https://www.lucintel.com/microrna-market.aspx

 

Metabolomics Market:

For more details click here https://www.lucintel.com/metabolomics-market.aspx

 

Industrial Microbiology Market:

For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx

 

Surgical Instrument Tracking System Market:

For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx

 

Tumor Ablation Market:

For more details click here https://www.lucintel.com/tumor-ablation-market.aspx

 

Induced Pluripotent Stem Cell Market:

For more details click here https://www.lucintel.com/induced-pluripotent-stem-cell-market.aspx

 

Cell Delivery Market:

For more details click here https://www.lucintel.com/cell-delivery-market.aspx

 

Gene Expression Market:

For more details click here https://www.lucintel.com/gene-expression-market.aspx